XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,387,000 | -12.9% | 1,815,091 | -3.5% | 0.06% | -11.1% |
| Q1 2021 | $8,482,000 | -13.0% | 1,880,722 | -5.1% | 0.06% | -17.1% |
| Q4 2020 | $9,751,000 | -20.8% | 1,981,909 | -4.5% | 0.08% | -35.0% |
| Q3 2020 | $12,307,000 | +104.5% | 2,075,387 | -8.3% | 0.12% | +88.7% |
| Q2 2020 | $6,019,000 | +31.8% | 2,262,608 | -3.4% | 0.06% | +3.3% |
| Q1 2020 | $4,567,000 | -66.4% | 2,341,902 | +21.4% | 0.06% | -50.4% |
| Q4 2019 | $13,595,000 | -16.5% | 1,928,308 | +16.4% | 0.12% | -25.3% |
| Q3 2019 | $16,283,000 | +1.1% | 1,656,422 | +17.7% | 0.16% | +4.5% |
| Q2 2019 | $16,105,000 | +14.6% | 1,407,786 | +0.6% | 0.16% | +17.4% |
| Q1 2019 | $14,053,000 | +26.6% | 1,399,711 | +114.4% | 0.13% | +13.8% |
| Q4 2018 | $11,097,000 | 0.0% | 652,748 | +3.4% | 0.12% | +24.7% |
| Q3 2018 | $11,097,000 | -1.8% | 631,236 | +6.1% | 0.09% | -10.6% |
| Q2 2018 | $11,297,000 | – | 595,202 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |